No Heading
Purpose.
The prophylactic role of liposomized chloroquine (lip-CQ) has been assessed against less susceptible Cryptococcus neoformans infection in murine model.
Methods.
In the current study, we investigated the antifungal activity of lip-CQ against C. neoformans in macrophages cell line (J 774) and murine model. Mice were pretreated with free as well as liposomized formulations of CQ at various doses. The anticryptococcal activity of fluconazole was compared in mice with or without CQ pretreatment. The efficacy of CQ prophylaxis was assessed by survival as well as colony forming units (cfu) in brain and lungs of treated mice.
Results.
Fluconazole alone was not found significantly effective against C. neoformans in both in vitro and in vivo studies. However, the antifungal activity of fluconazole increases in chloroquine-pretreated mice. Lip-CQ was found to be more effective in comparison to the same dose of free chloroquine in reducing fungal burden from macrophages in vitro and lungs and brain of C. neoformans infected mice.
Conclusions.
The enhanced prophylactic activity of lip-CQ seems due to rapid uptake of drug-containing liposomes by macrophages. The liposome-mediated accumulation of CQ in macrophages makes the environment unfavorable (alkaline) for the intracellular multiplication of C. neoformans. Moreover, the increased incidence of multidrug resistance and diversity of pathogenic microorganisms inhibited or killed by CQ makes it the drug of choice for prophylactic therapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
1. N. Singh. Trends in the epidemiology of oppotunistic fungal infections: predisposing factors and the impact of antimicrobial use practices. Clin. Infect. Dis. 33:1692–1696 (2001).
2. W. G. Powderly. Cryptococcal meningitis and AIDS. Clin. Infect. Dis. 17:837–842 (1993).
3. S. M. Levitz, Nong, Shu-Hua., K.F. Seetoo, T. S. Harrison, R. A. Speizer, and E.R. Simons. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885–890 (1999).
4. W. C. Chen, D. L. Chou, and D. S. Feingold. Dissociation between ion permeability and the lethal action of polyene antibiotics on C. albicans. Antimicrob. Agents Chemother. 13:914–917 (1978).
5. R. Horn, B. Wong, T.E. Kiehn, and D. Armstrong. Fungemia in a cancer hospital: changing frequency, earlier onset and results of therapy. Rev. Infect. Dis. 7:646–655 (1985).
6. U. E. Schaible, S. Sturgill-Koszycki, P. H. Schlesinger, and D. G. Russell. Cytokine activation leads to acidification and increases maturation of Mycobacterium avium-containing phagosomes in murine macrophages. J. Immunol. 160:1290–1296 (1998).
7. L. D. Sibley, E. Weidner, and J. L. Krahenbuhl. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 315:416–419 (1985).
8. M. A. Horwitz and F. R. Maxfield. Legionella pneumophila inhibits acidification of its phagosome in human monocytes. J. Cell Biol. 99:1936–1943 (1984).
9. D. J. Krogstad and P. H. Schlesinger. Acid-vesicle function, intracellular pathogens and action of chloroquine against Plasmodium falciparum. N. Engl. J. Med. 317:542–549 (1987).
10. T. F. Byrd and M. A. Horwitz. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of the iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J. Clin. Invest. 88:351–357 (1991).
11. S. L. Newman, L. Gootee, G. Brunner, and G. S. Deepe Jr. Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of the intracellular iron and is therapeutic in murine model of histoplasmosis. J. Clin. Invest. 93:1422–1429 (1994).
12. A. H. Fortier, D. A. Leiby, R. B. Narayan, E. Asafodjei, R. M. Crawford, C. A. Nansy, and M. A. Mitzer. Growth of Francisella tulerensis LVS in macrophages: the acidic intracellular environment provides essential intracellular iron required for growth. Infect. Immun. 63:1478–1483 (1995).
13. S. M. Levitz, S. T. Harrison, T. Abdulmoneim, and L. Xiuping. Chloroquine induces human mononuclear phagocytes to inhibit and kill Cryptococcus neoformans by a mechanism independent of iron deprivation. J. Clin. Invest. 100:1640–1646 (1997).
14. J. J. Bergers, T. L. ten Hagen, E. W. Van Etten, and I. A. Bakker-Woudenberg. Liposomes as delivery systems in the prevention and treatment of infectious diseases. Pharm. World Sci. 17(1):1–11 (1995).
15. W. S. Singleton, M. S. Gray, and M. L. Brown. A method for adsorbent fractionation of cottonseed oil for experimental intravenous fat emulsions. J. Am. Oil Chem. Soc. 42:53–56 (1965).
16. M. Owais, G. C. Varshney, A. Choudhury, S. Chandra, and C. M. Gupta. Chloroquine encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. Antimicrob. Agents Chemother. 39(1):180–184 (1995).
17. M. Owais and C. M. Gupta. Liposome mediated cytosolic delivery of macromolecules and its possible role in vaccine development. Eur. J. Biochem. 267:3946–3956 (2000).
18. National Committee for Clinical Laboratory Standards. Reference Method for broth dilution antifungal susceptibility testing for yeasts. Approved standard M 27-A. National Committee for Clinical Laboratory Standards, Villanova, PA, 1995.
19. M. A. Khan, S. M. Faisal, W. Haque, and M. Owais. Immunomodulator tuftsin augments antifungal activity of Amp B against experimental murine candidiasis. J. Drug Targetting. 10:185–192 (2002).
20. T. Harrison, G. Griffin, and S. Levitz. Conditional lethality of the diprotic weak bases chloroquine and quinacrine against Cryptococcus neoformans. J. Infect. Dis. 182:283–289 (2000).
21. R. Mazzolla, R. Barluzzi, A. Brozzetti, J. R. Boelaert, T. Luna, S. Saleppico, F. Bistoni, and E. Blasi. Enhanced resistance to Cryptococcus neoformans infection induced by chloroquine in a murine model of meningoencephalitis. Antimicrob. Agents Chemother. 41:802–807 (1997).
22. J. M. Orenstein, C. Fox, and S. M. Wahl. Macrophages as a source of HIV during opportunistic infections. Science 276:1857–1861 (1997).
23. S. M. Weber and S. M. Levitz. Chloroquine antagonizes the proinflammatory cytokine response to opportunistic fungi by alkalizing the fungal phagolysosome. J. Infect. Dis. 183:935–942 (2001).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khan, M., Jabeen, R. & Mohammad, O. Prophylactic Role of Liposomized Chloroquine Against Murine Cryptococcosis Less Susceptible to Fluconazole. Pharm Res 21, 2207–2212 (2004). https://doi.org/10.1007/s11095-004-7672-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-004-7672-8